|
Volumn 31, Issue 5, 2006, Pages 447-451
|
How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG SAFETY;
ELECTROPORATION;
FEMALE;
HEAD AND NECK CANCER;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MALE;
MULTIMODALITY CANCER THERAPY;
PRIORITY JOURNAL;
SKIN CANCER;
SKIN TUMOR;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBIOTICS, ANTINEOPLASTIC;
BLEOMYCIN;
CARCINOMA, BASAL CELL;
CARCINOMA, MERKEL CELL;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
ELECTROPORATION;
FEMALE;
FOLLOW-UP STUDIES;
HEAD AND NECK NEOPLASMS;
HUMANS;
MALE;
MELANOMA;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NETHERLANDS;
SALIVARY GLAND NEOPLASMS;
SARCOMA;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
TUMOR BURDEN;
|
EID: 33749432108
PISSN: 17494478
EISSN: 17494486
Source Type: Journal
DOI: 10.1111/j.1749-4486.2006.01198.x Document Type: Article |
Times cited : (22)
|
References (5)
|